Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.
Perspectives on Safety and Efficacy-The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis.
Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study.
The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing.
Autoimmunity in 2015.
Microglia Ontology and Signaling.
Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.
Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.
Acute Transverse Myelitis and Nicolau Syndrome after Benzathine Penicillin Injection.
Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.
Cortical gray and subcortical white matter associations in Parkinson's disease.
Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
T-cell activation and HLA-regulated response to smoking in the deep airways of patients with multiple sclerosis.
Relationships between trunk performance, gait and postural control in persons with multiple sclerosis.
Anconeus Epitrochlearis Muscle Causing Ulnar Neuropathy at the Elbow: Clinical and Neurophysiological Differential Diagnosis.
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
Report: Stem cell applications in neurological practice, an expert group consensus appraisal.
Pediatric multiple sclerosis: Conventional first-line treatment and general management.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NO.
Intraneural injection of a test dose of local anesthetic in peripheral nerves - does it induce histological changes in nerve tissue?
Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: Implications for screening, clinical care and endurance and resistance exercise therapy, a scoping review.
The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.

Pages